Valvular disease, Atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients 20 years of age or older at the time of mitral valve plasty or mitral valve replacement (1) Patients who underwent cardiac MRI prior to mitral valve plasty or mitral valve replacement (3) Patients for whom written consent has been obtained by the individual
Exclusion criteria
Exclusion criteria: (1) Patients taking steroids, autoimmune diseases, undergoing treatment for cancer, or suffering from hepatitis B and C viruses (2) Other patients who are deemed inappropriate by the physician in charge of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cluster analysis of single-cell RNA sequencing and cluster analysis of gene expression variation in each cluster on both left atrial tissue with late gadolinium enhancement on cardiac MRI and left atrial tissue without | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Bulk RNA sequencing 2.single cell ATAC sequencing 3.Histological evaluation 4.single cell RNA sequencing of blood sample | — |
Countries
Japan
Contacts
Kobe University Hospital The division of Cardiovascular medicine